Advancing Mental Health with Precision

Revolutionizing Psychiatric Diagnosis Through Innovation

Empowering mental health care specialists with a first-of-its-kind diagnostic device, our technology diagnose and distinguishes mental health disorders with precision, identifying at-risk individuals and guiding treatment.

Use Case

Bringing Precision Medicine to Mental Health.

We are dedicated to tackling the mental health crisis head-on. With our innovative diagnostic device, we empower mental health care specialists to provide precise diagnoses and tailored treatments to patients.

1-15 years

The actual experience and timeline can vary significantly for each individual based on factors such as the severity of symptoms, access to healthcare, social support, and individual response to treatment. Early recognition of symptoms and prompt intervention can improve outcomes.

Patient Health

Individual costs touch on every aspect related to one’s quality of life, from loss of productivity, autonomy, finances, and time.

Cost on Society

The overlap between individual costs and societal costs when a person experiences mental health issues is significant and multifaceted.

Market size

Market Overview

The psychosis diagnostics market is on a robust growth trajectory, evidenced by a jump from US$ 2.04 Billion in 2022 to a projected US$ 3.6 Billion by 2033, expanding at a CAGR of 5.3%​​.

$5.6B
Market value for psychosis only
(USA + CAN)
11M+
People that will have a psychotic episode in their lifetimes (USA + CAN)
$2.5T
Impact of mental health disorders on the global economy
50%
Lifetime prevalence of mental health issues
13.2%
of population with a severe
and handicapping mental disorder
8%
Psychiatric
Diagnosis
5.2%
Misdiagnosed

Advisers, Partners & Sponsors

Join the Mental Health Revolution
Be Part of the Solution

© OneCare Biotechnologies All rights reserved